Comparison Between the Analgesic Efficacy of Erector Spinae Plane Block and Psoas Compartment Block in Hip Surgery

Not Applicable

• Conditions: Hip Arthropathy
• Interventions: Procedure: Control Group (GROUP III); Procedure: Psoas Compartment Block Group (GROUP I); Procedure: Erector Spinae Plane block ( Group II)

• Registration Number: NCT03904095
• Lead Sponsor: TC Erciyes University

Brief Summary

To evaluate the ability of Erector spina Plane block and Psoas compartment block to decrease postoperative pain and analgesia requirements in patients undergoing hip surgery.

Detailed Description

Erector spina Plane block or Psoas compartment block will performed with guided ultrasound at L4 Transverse process level would lead to adequate postoperative analgesia ,in total hip arthroplasty surgeries.

Study Timeline

• Study Start: 2019-02-01
• Study First Submitted: 2019-03-28
• Status Verified: 2019-04
• Study First Submitted QC: 2019-04-03
• Study First Posted: 2019-04-04
• Last Update Submitted: 2019-04-04
• Last Update Posted: 2019-04-08
• Primary Completion: 2022-02-01
• Study Completion: 2022-02-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

ASA (American Society of Anesthesiologists) I- ASA II Patients

Exclusion Criteria

• history of allergy to the study medication
• refusal to participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
The Control group	Control Group (GROUP III)	The Control group receive no intervention ( Group III).
Psoas compartment block group (PCB)	Psoas Compartment Block Group (GROUP I)	Single- shot ultrasound (Esaote Mylab30) guided PCB with 15 ml 0.25% bupivacain ( Marcain 0.5%, Astra zeneca, Turkey) at the L4 vertebral level will performed preoperatively to patients in the PCB group (Group I).
Erector spinae plane block group (ESP)	Erector Spinae Plane block ( Group II)	Single- shot ultrasound (Esaote Mylab30) guided ESP block with 15 ml 0.25% ( Marcain 0.5%, Astra zeneca, Turkey) at the L4 vertebral level will performed preoperatively to patients in the ESP group (Group II).

Primary Outcome Measures

Name	Time	Method
opioid consumption	24 hours after surgery	In the recovery room, all patients will given a patient- controlled analgesia device containing morphine 0.5 mg/ml, set to deliver a 1mg bolus dose of morphine with an 15 min lockout time and 6 mg 1 h limit.Total morphine consumption during the 24 hours postoperative period will recorded at 5 times intervals ( 2, 4, 6, 12, 24 hours).
Verbal analog Pain Scores on rest and movement	24 hours after surgery	A Research assistant, blinded to the group allocation, interviewed patients and collected data at 5 times intervals ( 2, 4, 6, 12, 24, hours) in the 24 hours postoperatively. Patients were asked to rate their pain using verbal analog scale, where 0= no pain and 10= worst pain possible.

Secondary Outcome Measures

Name	Time	Method
incidences of adverse effects (like nausea and vomiting)	24 hours after surgery	incidences of nausea and vomiting during the 24 hours postoperative period will recorded at 6 time intervals ( 2, 4, 6, 12, 24 hours).

Trial Locations

Locations (1)

Sibel Seçkin Pehlivan; 🇹🇷 Kayseri, Talas, Turkey